教育经历 1999.9 – 2003.6 复旦大学药学院药学专业,获学士学位
2003.9 – 2008.6 复旦大学药学院药剂学专业,获博士学位
工作经历
2008.7 – 2011.8 复旦大学药学院,讲师
2010.2 – 2010.8 德国慕尼黑大学药学院,博士后
2015.8 – 2016.8 加州大学伯克利分校,访问学者
2011.9 – 至今 复旦大学药学院,副教授
专家类别副教授,上海市晨光计划、浦江人才入选者,上海市浦东新区科技发展基金专家,复旦大学首届卓学计划入选者
职务
博士生导师
承担科研项目情况
1. 国家自然科学基金面上项目,可视化的级联靶向胶束联合治疗脑胶质瘤的研究
2. 中德合作研究项目,新型多肽修饰的精确寡聚体级联靶向基因治疗脑胶质瘤的研究
3. 国家自然科学基金青年项目,T7肽修饰的靶向脑胶质瘤双载药纳米递释系统的构建及其靶向机制研究
4. 上海市晨光计划项目,穿膜肽修饰基因递释系统及其抗肿瘤研究
5. 复旦大学首届卓学计划项目,脑胶质瘤靶向药物递释研究
6. 教育部新教师基金项目,Angiopep修饰纳米基因递释系统的脑靶向机制及其抗帕金森病的研究
7. 技术开发项目,多功能纳米载药系统的制备及其协同靶向治疗脑胶质瘤的研究
8. 复旦大学聚合物分子工程国家重点实验室开放课题,基于介孔硅-石墨烯纳米片的脑胶质瘤靶向药物递释系统
获奖及荣誉
2016 中国药学会第十三届青年药学科研成果交流会优秀论文二等奖
2014 “Merck-Fudan Scholarship for Excellent Young Teachers”
2012 复旦大学“港爱赞助优异奖教金”
2011 复旦大学“第一三共制药”奖教金
2011 教育部科学研究优秀成果一等奖(排名第六)
2010 上海市科学技术奖二等奖(排名第五)
2010 全国优秀博士学位论文提名奖
2009 上海市优秀博士论文
2008 “全国药学博士论坛优秀报告一等奖”
已发表学术论文49篇,其中通讯作者和第一作者SCI论文27篇,其中IF>10 的论文3篇,IF>5的论文>60%,如JACS、ACS Nano、Biomaterials、Small、JMC等材料、化学和生物医学领域的国际权威期刊。发表论文总SCI他引超过1500次,SCI“H-index”为25。作为第一申请人申请专利11项,授权专利3项。
代表性论文如下:
1. Meng Y, Wang SS, Li CY, Qian M, Yan XY, Yao SC, Peng XY, Wang Y*, Huang RQ*. Photothermal combined gene therapy achieved by polyethyleneimine-grafted oxidized mesoporous carbon nanospheres. Biomaterials, 2016, 100:134-42. (IF = 8.387)
2. Li CY, Meng Y, Wang SS, Qian M, Wang JX, Lu WY, Huang RQ*. Mesoporous Carbon Nanospheres Featured Fluorescent Aptasensor for Multiple Diagnosis of Cancer in Vitro and in Vivo. ACS Nano. 2015, 9(12):12096-103. (IF = 13.334) (X-MOL邀请报道:http://www.x-mol.com/news/1605)
3. Wang Y, Meng Y, Wang SS, Li CY, Shi W, Chen J, Wang JX, Huang RQ*. Direct solvent-derived polymer-coated nitrogen-doped carbon nanodots with high water solubility for targeted fluorescence imaging of glioma. Small. 2015, 11(29):3575-81. (IF = 8.368, cover page)
4. Wang KY, Yao H, Meng Y, Wang Y*, Yan XY*, Huang RQ*. Specific aptamer-conjugated mesoporous silica-carbon nanoparticles for HER2-targeted chemo-photothermal combined therapy. Acta Biomater. 2015, 16:196-205. (IF = 6.025)
5. Yao H, Wang KY, Wang Y, Wang SS, Li JF, Lou JN, Ye LY, Yan XY, Lu WY, Huang RQ*. Enhanced blood-brain barrier penetration and glioma therapy mediated by a new peptide modified gene delivery system. Biomaterials. 2015, 37:345-52. (IF = 8.557)
6. Wang Y, Wang KY, Zhang R, Liu XG, Yan XY, Wang JX, Wagner E, Huang RQ*. Synthesis of core-shell graphitic carbon@silica nanospheres with dual-ordered mesopores for cancer-targeted photothermochemotherapy. ACS Nano. 2014, 8(8):7870-9. (IF = 12.881)
7. Wang Y#, Huang RQ#, Liang GH, Zhang ZY, Zhang P, Yu SN, Kong JL. MRI-visualized, dual-targeting and combined tumor therapy using magnetic draphene-based mesoporous silica. Small. 2014, 10(1):109-16. (IF = 8.368, cover page)
8. Wang Y, Wang KY, Yan XY, Huang RQ*. A general strategy for dual-triggered combined tumor therapy based on template semi-graphitized mesoporous silica nanoparticles. Adv. Healthc. Mater. 2014, 3(4):485-9. (IF = 5.797)
9. Wang Y, Wang KY, Zhao JF, Liu XG, Bu J, Yan XY, Huang RQ*. Multifunctional mesoporous silica-coated graphene nanosheet used for chemo-photothermal synergistic targeted therapy of glioma. J. Am. Chem. Soc. 2013, 135(12):4799-804.(IF = 11.444)
10. Wang Y#, Shi W#, Song WS, Wang L, Liu XG, Chen J*, Huang RQ*. Tumor cell targeted delivery by specific peptide-modified mesoporous silica nanoparticles. J. Mater. Chem. 2012, 22(29):14608-16.(IF=6.108)
11. Huang RQ, Han L, Li JF, Liu SH, Shao K, Kuang YY, Hu X, Wang XX, Lei H, Jiang C. Chlorotoxin-modified macromolecular contrast agent for MRI tumor diagnosis. Biomaterials. 2011, 32(22):5177-86. (IF = 7.404)
12. Huang RQ, Ke WL, Han L, Li JF, Liu SH, Jiang C. Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration. Biomaterials. 2010, 32(9):2399-406. (IF = 7.404)